본문바로가기
Q
U
I
C
K

Global Innovative Partner of Vaccine and Biotech SK bioscience

From Prevention To Cure
mouse scroll icon SCROLL DOWN

Our Science & Technology

Conducting research into vaccines that will be the driving force in the life science business going forward.

The world's best vaccine factory with advanced vaccine technology.

Leading in expanding the global market through cooperation with global companies.

What’s New

  • SK bioscience News SK bioscience and Korea Disease Con...

    Company aims to develop a bird flu vaccine with rapid mass production and variant responsiveness.SK ...

    More
  • News SK bioscience and IVI Host 202...

    Commissioner Youngmee Jee of the Korea Disease Con...

    More
  • News SK bioscience Wins Patent Inva...

    SK bioscience wins case two years after filing sui...

    More
  • News SK bioscience and IVI Announce...

    -Award established in 2021 to honor the legacy of ...

    More
  • News SK bioscience Expands Influenz...

    750,000 doses of influenza vaccine to be supplied ...

    More

Investor Relations

0 PRESENT PRICE (WON)

0WON

0.00%

Our Products





PRODUCTS

SKYCellflu® Quadrivalent

SKYCellflu® Quadrivalent

[13494] 310, Pangyo-ro, Bundang-gu, Seongnam-si, Gyeonggi-do, Republic of Korea
Company Registration Number 818-86-00991

Copyright(c) SK bioscience. All Right Reserved

접근성 마크
  GO